Investor Conference Call:
ChromaDex Corp. (NASDAQ:CDXC) declared that it will hold a conference call on Wednesday, Nov. 3, 2021 at 4:30 p.m. ET to talk about its monetary outcomes for the second from last quarter finished Sep. 30, 2021. The monetary outcomes will be reported in a press release after the end of regular stock market trading hours on the same day as the conference call.
ChromaDex management will host an investor conference call to discuss the third quarter results and provide a general business update on Wednesday, Nov. 3, at 4:30 p.m. ET.
Participants should call in at least 10 minutes prior to the call. The dial-in information is as follows:
Date: Wednesday, Nov. 3, 2021
Time: 4:30 p.m. ET (1:30 p.m. Pacific time)
Toll-free dial-in number: 1-888-510-2008
Conference ID: 4126168
The conference call will be broadcast live and available for replay here and via the investor relations section of the Company’s website at www.chromadex.com.
A replay of the conference call will be available from 7:30 p.m. ET on Nov. 3, 2021, to 11:59 p.m. ET on Nov. 10, 2021.
Toll-free replay number: 800-770-2030
Replay ID: 4126168
About ChromaDex: ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product Tru Niagen® available at www.truniagen.com and through partnerships with global retailers and distributors. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week